21 Patents
- 0 cites
- US1252881520265-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one Compounds for Use Against Cancer
Nxera Pharma UK Limited
0 cites - US124921742025Morpholine-3-carboxamide Derivatives as Prostaglandin E2 Receptor 4 (EP4) Agonists for the Treatment of Gastrointestinal and Pulmonary Diseases
Nxera Pharma UK Limited
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- US122150992025Quinolinone and Benzoxazine Derivatives as Muscarinic M 1 And/or M 4 Receptor Agonists
Nxera Pharma UK Limited
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- US119876482024Cyclohexapeptides as Selective Somatostatin SST5 Receptor Agonists
Heptares Therapeutics Limited
0 cites - US118344072023Substituted Cyclohexanes as Muscarinic M1 Receptor And/or M4 Receptor Agonists
Heptares Therapeutics Limited
0 cites - 0 cites
- US116800532023Methods of Treatment Using 4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators
Heptares Therapeutics Limited
0 cites - US115847322023Methods of Treatment Using 4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators
Heptares Therapeutics Limited
0 cites